| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | +7.24% | +0.99% | +6.25% | +6.25% | — |
| 14d | 2 | +0.00% | +10.92% | +1.33% | +9.60% | +9.60% | — |
| 30d | 2 | +0.00% | +7.08% | -0.60% | +7.68% | +7.68% | — |
| 60d | 2 | +50.00% | +1.01% | -5.25% | +6.26% | +6.26% | — |
| 90d | 2 | +0.00% | +8.54% | -1.80% | +10.34% | +10.34% | — |
| 180d | 2 | +50.00% | +28.90% | +8.66% | +20.24% | +20.24% | — |
| 1y | 2 | +0.00% | +27.70% | +18.84% | +8.86% | +8.86% | — |
| 2y | 2(1 pending) | +0.00% | +84.45% | +42.90% | +41.55% | +41.55% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 2,875 | — | — | 2,875 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 2,875 | — | — | 11,522 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| TRVI TREVI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 375,000 | — | — | 375,000 | Jan 8, 2026 | Jan 12, 2026 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 23,000 | — | — | 69,183 | Jun 26, 2025 | Jun 30, 2025 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 23,000 | — | — | 23,000 | Jun 26, 2025 | Jun 30, 2025 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 90,100 | — | — | 249,824 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 365,800 | — | — | 365,800 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | SALE10b5-1 10b5-1 plan | 22,183 | $3.28 | $72.8K | 159,724 | Feb 4, 2025 | Feb 5, 2025 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 23,000 | — | — | 23,000 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 23,000 | — | — | 46,183 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | SALE10b5-1 10b5-1 plan | 9,593 | $2.31 | $22.2K | 181,907 | Feb 2, 2024 | Feb 5, 2024 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 112,500 | — | — | 191,500 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 10,000 | — | — | 23,183 | Jun 15, 2023 | Jun 23, 2023 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 316,000 | — | — | 316,000 | Feb 1, 2023 | Feb 3, 2023 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 79,000 | — | — | 79,000 | Feb 1, 2023 | Feb 3, 2023 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Jun 17, 2022 | Jun 22, 2022 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 10,000 | — | — | 13,183 | Jun 17, 2022 | Jun 22, 2022 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 285,000 | $2.81 | $800.9K | 285,000 | Jan 20, 2022 | Jan 20, 2022 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Jun 16, 2021 | Jun 21, 2021 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Feb 13, 2021 | Feb 17, 2021 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 55,000 | — | — | 55,000 | Jul 6, 2020 | Mar 31, 2021 ↗ | View → |
| SCYX SCYNEXIS INC | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Jul 6, 2020 | Jul 8, 2020 ↗ | View → |
| ABUS ARBUTUS BIOPHARMA CORP | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Feb 17, 2020 | Feb 19, 2020 ↗ | View → |